DGAP-News: Supervisory Board of CytoTools AG expresses trust in the Management Board after the Annual General Meeting
Darmstadt, 7 December 2020 - The Supervisory Board of CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding company specializing in pharmaceutical and medical products, has, following the Annual General Meeting held virtually on 3rd December, expressed its trust in the Management Board of the company.
- Darmstadt, 7 December 2020 - The Supervisory Board of CytoTools AG (ISIN DE000A0KFRJ1), a biotechnology holding company specializing in pharmaceutical and medical products, has, following the Annual General Meeting held virtually on 3rd December, expressed its trust in the Management Board of the company.
- Thus, the decision of the Supervisory Board is in line with the will of the majority count (more than 98 percent) of the voting shareholders.
- At the same time, however, the Management Board is confident that the company will be successful even without these resolutions.
- Further information on CytoTools AG, its affiliated subsidiaries and the active substance pipeline of the holding company is available on the company website at www.cytotools.de.